The tumor control probabilities (TCPs) for 11 transperineal permanent
implants of the prostate With I-125 seeds have been computed, based on
target-specific volume-dose histogram data. Prostate dose-response of
this modality is converted from that of external beam therapy based o
n biologically effective dose derived from the alpha/beta model. The c
alculated TCPs for these transperineal prostate cases are compared wit
h the results of 679 previous retropubic implants, providing interesti
ng insight about these two techniques. Further refinement and validati
on of this model await long-term followup results of sufficient number
of patients.